These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16434782)

  • 1. Recognizing and treating depression in children and adolescents.
    Dopheide JA
    Am J Health Syst Pharm; 2006 Feb; 63(3):233-43. PubMed ID: 16434782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of children and adolescents with depression.
    Vitiello B; Ordóñez AE
    Expert Opin Pharmacother; 2016 Dec; 17(17):2273-2279. PubMed ID: 27690663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in the Pharmacotherapy of Adolescent Depression.
    Masi G
    Curr Pharm Des; 2022; 28(24):1975-1984. PubMed ID: 35619257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of suicidality in depression with serotonergic antidepressants.
    Matthews JD; Fava M
    Ann Clin Psychiatry; 2000 Mar; 12(1):43-50. PubMed ID: 10798825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacotherapy of major depressive disorder in adolescents.
    Masi G; Liboni F; Brovedani P
    Expert Opin Pharmacother; 2010 Feb; 11(3):375-86. PubMed ID: 20102303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug treatment of depression in children and adolescents].
    Grøholt B
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2243-5. PubMed ID: 22085951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant treatment for postnatal depression.
    Molyneaux E; Howard LM; McGeown HR; Karia AM; Trevillion K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002018. PubMed ID: 25211400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants: bitter pills.
    Check E
    Nature; 2004 Sep; 431(7005):122-4. PubMed ID: 15356601
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of regulatory warnings on antidepressant prescribing for children and adolescents.
    Kurian BT; Ray WA; Arbogast PG; Fuchs DC; Dudley JA; Cooper WO
    Arch Pediatr Adolesc Med; 2007 Jul; 161(7):690-6. PubMed ID: 17606833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents.
    Fontanella CA; Bridge JA; Marcus SC; Campo JV
    Ann Pharmacother; 2011 Jul; 45(7-8):898-909. PubMed ID: 21775691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood and adolescent depression.
    Bhatia SK; Bhatia SC
    Am Fam Physician; 2007 Jan; 75(1):73-80. PubMed ID: 17225707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.
    Katz LY; Kozyrskyj AL; Prior HJ; Enns MW; Cox BJ; Sareen J
    CMAJ; 2008 Apr; 178(8):1005-11. PubMed ID: 18390943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of treatment-resistant depression in children and adolescents.
    DeFilippis M; Wagner KD
    Paediatr Drugs; 2014 Oct; 16(5):353-61. PubMed ID: 25200567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.